EUVIMEDEUVIMED entdecken
Open Access

DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children’s Oncology Group and the Childhood Cancer Survivor Study

Xuexia Wang, Purnima Singh iD, Romina B Cejas iD, Liting Zhou, Noha Sharafeldin iD, Patrick J Trainor iD, Wendy Landier iD, Changde Cheng iD, Lindsey Hageman iD, Fan Wang iD, Yadav Sapkota iD, Yutaka Yasui iD und 9 weitere

Circulation: Genomic and Precision Medicine · 2025

DOI: 10.1161/circgen.124.004813 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Genomic and Precision Medicine, 2025. Verfasst von Xuexia Wang und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biostatistics, Florida International University, Miami (X.W.). Hauptthemen laut MEDLINE: Anthracyclines, Cancer Survivors, DNA Repair, Cardiomyopathies. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NHGRI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Anthracyclines induce cardiotoxicity via DNA double-strand breaks and reactive oxygen species formation, resulting in cardiomyocyte dysfunction. The role of DNA damage response/repair (DDR) genes in anthracycline-induced cardiomyopathy remains unstudied. METHODS: We conducted a gene-based and pathway-based analysis to examine the main effect and gene-anthracycline interaction effect between DDR genes and anthracycline-induced cardiomyopathy. A discovery analysis performed with a matched case-control set of anthracycline-exposed non-Hispanic White childhood cancer survivors from Children's Oncology Group-ALTE03N1 (113 cases; 226 controls) was replicated using a cohort of anthracycline-exposed non-Hispanic White childhood cancer survivors from the Childhood Cancer Survivor Study cohort (n=1658; 97 cases). Functional analyses were performed by examining the response to doxorubicin of human-induced pluripotent stem cell-derived cardiomyocytes with CRISPR/Cas9-mediated knockout of prioritized genes. RESULTS: Successfully replicated DDR genes demonstrating main-effect association included FANCC ( P =0.037) and XRCC5 ( P =0.001) and demonstrated gene-anthracycline interaction included MGMT ( P =0.041). Knockouts of FANCC and MGMT in human-induced pluripotent stem cell-derived cardiomyocytes demonstrated significant resistance to doxorubicin, suggesting that these genes play a role in anthracycline-induced cardiotoxicity. Successfully replicated DDR pathways demonstrating main-effect association included base excision repair ( P =2.7×10 −4 ); role of BRCA1 in DDR ( P =9.2×10 −5 ); p53 signaling ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnthracyclinesCancer SurvivorsDNA RepairCardiomyopathiesDNA DamageNeoplasmsHumansChildFemaleMaleAdolescentChild, PreschoolCase-Control StudiesMyocytes, Cardiac

Stichwörter der Autor:innen

DNA repairanthracyclinescardiomyopathiesneoplasmssurvivorship

Substanzen

Anthracyclines

Autor:innen und Institutionen

  • Department of Biostatistics, Florida International University, Miami (X.W.).
  • Department of Pediatrics (P.S., L.Z., P.J.T., W.L., L.H., S.B.).
  • Department of Pharmacology, Northwestern University, Chicago, IL (R.B.C., P. W. B.).
  • Department of Medicine, University of Alabama at Birmingham (N.S., C.C.).
  • Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN (F.W., Y. S., Y.Y., M.M. H., G.T.A.).
  • Department of Pediatrics, Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center (E.J.C., D.S.H.).

ORCID-Profile: Purnima Singh, Romina B Cejas, Noha Sharafeldin, Patrick J Trainor, Wendy Landier, Changde Cheng, Lindsey Hageman, Fan Wang, Yadav Sapkota, Yutaka Yasui, Melissa M Hudson, Eric J Chow, Saro H Armenian, Joseph P Neglia, Douglas S Hawkins, Jill P Ginsberg, Paul W Burridge, Gregory T Armstrong, Smita Bhatia

Förderung

  • NCI NIH HHS
  • NHGRI NIH HHS

Zitieren

APA

Wang, X., Singh, P., Cejas, R. B., Zhou, L., Sharafeldin, N., Trainor, P. J., Landier, W., Cheng, C., Hageman, L., Wang, F., Sapkota, Y., Yasui, Y., Hudson, M. M., Chow, E. J., Armenian, S. H., Neglia, J. P., Hawkins, D. S., Ginsberg, J. P., Burridge, P. W., …, & Bhatia, S. (2025). DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children’s Oncology Group and the Childhood Cancer Survivor Study. Circulation: Genomic and Precision Medicine. https://doi.org/10.1161/circgen.124.004813

Vancouver

Wang X, Singh P, Cejas RB, Zhou L, Sharafeldin N, Trainor PJ, et al. DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children’s Oncology Group and the Childhood Cancer Survivor Study. Circulation: Genomic and Precision Medicine. 2025. doi:10.1161/circgen.124.004813

BibTeX
@article{Wang2025,
  author = {Wang, Xuexia and Singh, Purnima and Cejas, Romina B and Zhou, Liting and Sharafeldin, Noha and Trainor, Patrick J and Landier, Wendy and Cheng, Changde and Hageman, Lindsey and Wang, Fan and Sapkota, Yadav and Yasui, Yutaka and Hudson, Melissa M and Chow, Eric J and Armenian, Saro H and Neglia, Joseph P and Hawkins, Douglas S and Ginsberg, Jill P and Burridge, Paul W and Armstrong, Gregory T and Bhatia, Smita},
  title = {DNA Damage Response and Repair Genes and Anthracycline-Induced Cardiomyopathy in Childhood Cancer Survivors: A Report From the Children’s Oncology Group and the Childhood Cancer Survivor Study},
  journal = {Circulation: Genomic and Precision Medicine},
  year = {2025},
  doi = {10.1161/circgen.124.004813}
}
Kostenlos starten →